GlassScriptMeisinger USA, LLC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$585Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
554clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Rs22 $22K associated (2023-2025)
- Utb24 $9,352 associated (2023-2025)
- B850-021-Fg $1,761 associated (2023-2025)
- Jk04 $1,721 associated (2023-2025)
- Cb0330fg $1,421 associated (2023-2025)
- Bmpba $1,318 associated (2023-2025)
- 883h-012-Fg $1,317 associated (2023-2025)
- B850-025-Fg $1,211 associated (2023-2025)
- Bmsba $1,184 associated (2023-2025)
- Moc24 $1,158 associated (2023-2025)
- 883h-016-Fg $1,104 associated (2023-2025)
- B850-018-Fg $1,030 associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Gary Dewood | Scottsdale, AZ | Dentist | $69,292.85 |
| Daniel Selner | Denver, CO | Dentist | $68,026.86 |
| Athas Kometas | Daytona Beach Shores, FL | General Practice (Dentist) | $60,472.40 |
| Justin Moody | Crawford, NE | Dentist | $51,067.85 |
| James Klim | Santa Rosa, CA | General Practice (Dentist) | $26,388.94 |
| Robert Campbell | Long Beach, CA | General Practice (Dentist) | $21,354.90 |
| Tarun Agarwal | Raleigh, NC | Dentist | $14,690.15 |
| Giles Horrocks | Boulder, CO | Periodontics | $12,964.92 |
| Daniel Cullum | Coeur D Alene, ID | Oral and Maxillofacial Surgery | $12,647.18 |
| Hom-Lay Wang | Ann Arbor, MI | Dentist | $11,842.83 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.